These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 21652065)
21. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells. Wang H; Agarwal P; Zhao S; Xu RX; Yu J; Lu X; He X Biomaterials; 2015 Dec; 72():74-89. PubMed ID: 26344365 [TBL] [Abstract][Full Text] [Related]
22. SiRNA drug delivery by biodegradable polymeric nanoparticles. Yuan X; Li L; Rathinavelu A; Hao J; Narasimhan M; He M; Heitlage V; Tam L; Viqar S; Salehi M J Nanosci Nanotechnol; 2006; 6(9-10):2821-8. PubMed ID: 17048488 [TBL] [Abstract][Full Text] [Related]
23. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method. Kashi TS; Eskandarion S; Esfandyari-Manesh M; Marashi SM; Samadi N; Fatemi SM; Atyabi F; Eshraghi S; Dinarvand R Int J Nanomedicine; 2012; 7():221-34. PubMed ID: 22275837 [TBL] [Abstract][Full Text] [Related]
24. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Panyam J; Labhasetwar V Adv Drug Deliv Rev; 2003 Feb; 55(3):329-47. PubMed ID: 12628320 [TBL] [Abstract][Full Text] [Related]
25. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Feng SS; Mei L; Anitha P; Gan CW; Zhou W Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012 [TBL] [Abstract][Full Text] [Related]
26. Poly(D,L-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: preparation, release kinetics and anticancer effect. Yang H; Li K; Liu Y; Liu Z; Miyoshi H J Nanosci Nanotechnol; 2009 Jan; 9(1):282-7. PubMed ID: 19441308 [TBL] [Abstract][Full Text] [Related]
27. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Rafiei P; Haddadi A Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163 [TBL] [Abstract][Full Text] [Related]
28. Brain-targeted delivery of trans-activating transcriptor-conjugated magnetic PLGA/lipid nanoparticles. Wen X; Wang K; Zhao Z; Zhang Y; Sun T; Zhang F; Wu J; Fu Y; Du Y; Zhang L; Sun Y; Liu Y; Ma K; Liu H; Song Y PLoS One; 2014; 9(9):e106652. PubMed ID: 25187980 [TBL] [Abstract][Full Text] [Related]
29. Biodegradable PLGA85/15 nanoparticles as a delivery vehicle for Chlamydia trachomatis recombinant MOMP-187 peptide. Taha MA; Singh SR; Dennis VA Nanotechnology; 2012 Aug; 23(32):325101. PubMed ID: 22824940 [TBL] [Abstract][Full Text] [Related]
34. Synthesis, construction, and evaluation of self-assembled nano-bacitracin A as an efficient antibacterial agent in vitro and in vivo. Hong W; Gao X; Qiu P; Yang J; Qiao M; Shi H; Zhang D; Tian C; Niu S; Liu M Int J Nanomedicine; 2017; 12():4691-4708. PubMed ID: 28721045 [TBL] [Abstract][Full Text] [Related]
35. Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody. Joung YK; Son S; Jang JY; Kwon MH; Park KD Pharm Res; 2012 Apr; 29(4):932-42. PubMed ID: 22139535 [TBL] [Abstract][Full Text] [Related]
36. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins. Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502 [TBL] [Abstract][Full Text] [Related]
37. Drug-loaded PLGA nanoparticles for oral administration: fundamental issues and challenges ahead. Crit Rev Ther Drug Carrier Syst; ; . PubMed ID: 22475089 [TBL] [Abstract][Full Text] [Related]